Two Sigma Securities LLC decreased its stake in Colgate-Palmolive Company (NYSE:CL) by 86.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,443 shares of the company’s stock after selling 22,660 shares during the period. Two Sigma Securities LLC’s holdings in Colgate-Palmolive were worth $252,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Gulf International Bank UK Ltd increased its stake in Colgate-Palmolive by 2.2% in the first quarter. Gulf International Bank UK Ltd now owns 263,048 shares of the company’s stock valued at $19,252,000 after buying an additional 5,650 shares during the period. Chesley Taft & Associates LLC increased its stake in Colgate-Palmolive by 0.8% in the first quarter. Chesley Taft & Associates LLC now owns 28,197 shares of the company’s stock valued at $2,064,000 after buying an additional 225 shares during the period. Forte Capital LLC ADV increased its stake in Colgate-Palmolive by 12.1% in the first quarter. Forte Capital LLC ADV now owns 5,960 shares of the company’s stock valued at $436,000 after buying an additional 645 shares during the period. Stock Yards Bank & Trust Co. increased its stake in Colgate-Palmolive by 28.1% in the first quarter. Stock Yards Bank & Trust Co. now owns 11,844 shares of the company’s stock valued at $867,000 after buying an additional 2,600 shares during the period. Finally, Burke & Herbert Bank & Trust Co. increased its stake in Colgate-Palmolive by 0.5% in the first quarter. Burke & Herbert Bank & Trust Co. now owns 7,020 shares of the company’s stock valued at $514,000 after buying an additional 37 shares during the period. Institutional investors and hedge funds own 73.85% of the company’s stock.

Shares of Colgate-Palmolive Company (NYSE:CL) traded down 0.22% during midday trading on Thursday, hitting $71.41. The stock had a trading volume of 432,460 shares. The firm has a 50 day moving average price of $73.08 and a 200 day moving average price of $72.72. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27. The stock has a market cap of $62.90 billion, a PE ratio of 26.54 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter in the prior year, the business posted $0.70 EPS. The business’s revenue for the quarter was down .5% on a year-over-year basis. On average, equities analysts forecast that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be issued a $0.40 dividend. The ex-dividend date is Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. Colgate-Palmolive’s payout ratio is currently 59.48%.

COPYRIGHT VIOLATION NOTICE: “Colgate-Palmolive Company (NYSE:CL) Shares Sold by Two Sigma Securities LLC” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://www.watchlistnews.com/colgate-palmolive-company-nysecl-shares-sold-by-two-sigma-securities-llc/1470844.html.

Several research firms have recently weighed in on CL. Bank of America Corporation lifted their target price on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, May 31st. BidaskClub downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Vetr downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price for the company. in a research report on Wednesday, May 17th. Royal Bank Of Canada reiterated a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a research report on Thursday, May 25th. Finally, Jefferies Group LLC began coverage on Colgate-Palmolive in a research report on Tuesday, April 18th. They set a “hold” rating and a $78.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $75.82.

In related news, CFO Dennis J. Hickey sold 73,872 shares of the firm’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total transaction of $5,304,009.60. Following the transaction, the chief financial officer now owns 484,985 shares in the company, valued at approximately $34,821,923. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Vice Chairman Franck J. Moison sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $71.52, for a total value of $2,503,200.00. Following the transaction, the insider now owns 201,411 shares in the company, valued at approximately $14,404,914.72. The disclosure for this sale can be found here. In the last quarter, insiders sold 203,969 shares of company stock worth $14,711,068. Company insiders own 1.02% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.